Dasatinib bridging and haploidentical allogeneic hematopoietic cell transplantation in KIT D816V-negative mast cell leukemia: a case report (Mast cell leukemia successfully treated with HCT)
Japanese Journal of Transplantation and Cellular Therapy · 2026 · 15 (2) · 79-83
DOI: 10.7889/tct-25-020 ↗Kurz gefasst
Fallbericht in der Zeitschrift Japanese Journal of Transplantation and Cellular Therapy, 2026. Verfasst von Atsushi Otani und 6 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Otani, A., Ochi, S., Uchihara, M., Kobayashi, S., Yamaguchi, S., Matoba, Y., & Yagi, H. (2026). Dasatinib bridging and haploidentical allogeneic hematopoietic cell transplantation in KIT D816V-negative mast cell leukemia: a case report (Mast cell leukemia successfully treated with HCT). Japanese Journal of Transplantation and Cellular Therapy, 15(2), 79-83. https://doi.org/10.7889/tct-25-020
Vancouver
Otani A, Ochi S, Uchihara M, Kobayashi S, Yamaguchi S, Matoba Y, et al. Dasatinib bridging and haploidentical allogeneic hematopoietic cell transplantation in KIT D816V-negative mast cell leukemia: a case report (Mast cell leukemia successfully treated with HCT). Japanese Journal of Transplantation and Cellular Therapy. 2026;15(2):79-83. doi:10.7889/tct-25-020
BibTeX
@article{Otani2026,
author = {Otani, Atsushi and Ochi, Shinichi and Uchihara, Masahito and Kobayashi, Shinya and Yamaguchi, Shota and Matoba, Yusuke and Yagi, Hideo},
title = {Dasatinib bridging and haploidentical allogeneic hematopoietic cell transplantation in KIT D816V-negative mast cell leukemia: a case report (Mast cell leukemia successfully treated with HCT)},
journal = {Japanese Journal of Transplantation and Cellular Therapy},
year = {2026},
volume = {15},
number = {2},
pages = {79--83},
doi = {10.7889/tct-25-020}
}
EUVIMED